Clik here to view.
Making sense of value-based healthcare and how medtech companies should respond
Welcome to the Medsider interview series, a special new feature at MassDevice, which will appear regularly. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG....
View ArticleClik here to view.
Santen buys microshunt maker InnFocus for $225m
Santen Pharmaceuticals said today it picked up glaucoma-treating Microshunt developer InnFocus for $225 million, plus additional consideration upon reaching certain milestones. The Microshunt system is...
View ArticleClik here to view.
Cambridge Medical Robotics raises $20m in Series A
Cambridge Medical Robotics said yesterday it raised $20.3 million in a Series A round of funding to support the commercialization of its medical robotic technology. The company’s surgical robot is...
View ArticleClik here to view.
Cheetah Medical inks supply deal with Allina Health
Cheetah Medical said today it inked a supplier contract with non-for-profit healthcare system Allina Health. Through the contract, Minnesota and western Wisconsin based Allina Health will gain access...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for July 19, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Intuitive Surgical jumps on Q2 beats
Intuitive Surgical (NSDQ:ISRG) shares jumped in after-hours trading yesterday as investors reacted to 2nd-quarter numbers that handily topped expectations on Wall Street. The robot-assisted surgery...
View ArticleClik here to view.
Addressing global challenges through transatlantic cooperation | FDAVoice blog
By: Howard Sklamberg, J.D., Lou Valdez, and Donald Prater Reflecting the broad scope of our transatlantic dialogue, we engaged on an array of issues, including supply chain safety, quality metrics,...
View ArticleClik here to view.
Boston Scientific to settle IRS beef for $275m
Boston Scientific (NYSE:BSX) said it agreed yesterday to pay the U.S. Internal Revenue Service $275 million plus interest to settle a tax beef dating back to its $26 billion acquisition of Guidant in...
View ArticleClik here to view.
St. Jude Medical ticks up on Q2 sales beat
St. Jude Medical (NYSE:STJ) shares are up today after the medical device company reported higher-than-expected sales for the 2nd quarter and met Wall Street’s consensus earnings forecast. Little...
View ArticleClik here to view.
Abbott rises on Q2 earnings, sales beats
Abbott (NYSE:ABT) saw its stock rise today after reporting earnings and sales that came in above the consensus outlook on Wall Street. The Abbott Park, Ill.-based healthcare giant posted profits of...
View ArticleClik here to view.
US medical device market path defined in 10 key terms
By Debra Grodt, Director of Regulatory Affairs, Medical Device & Diagnostics, Novella Clinical What is a regulatory assessment? A regulatory assessment is a comprehensive review of Food & Drug...
View ArticleClik here to view.
Medtronic wins 1st FDA nod for cement-augmented spine screws
Medtronic (NYSE:MDT) said today it won FDA 510(k) clearance for its CD Horizon fenestrated cement-augmented spinal pedicle screw set, designed to be used with Medtronic’s HV-R polymethylmethacrylate...
View ArticleClik here to view.
FDA warns Oscor on process control records
The FDA last month warned contract manufacturer Oscor on its methods for documenting process controls for the catheters and neurostimulation leads it makes, after inspections in February and March...
View ArticleClik here to view.
FDA readies panel on diabetes dosing label for Dexcom’s G5 CGM
The FDA yesterday released information on a panel its holding over Dexcom Inc.‘s (NSDQ:DXCM) G5 continuous glucose monitor, as the company seeks an expanded indication. The new indication would allow...
View ArticleClik here to view.
Your inhaler’s watching you: drugmakers race for smart devices
(Reuters) – Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers properly....
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for July 20, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
TE Connectivity gains on Q3 earnings beat
TE Connectivity (NYSE:TEL) shares are up today after the contract manufacturing giant beat expectations with its fiscal third-quarter earnings and said it would acquire German connector maker...
View ArticleClik here to view.
Reflexion adds $6m to bring Series B to $52m
California-based medtech group RefleXion Medical said yesterday it extended its Series B round of financing, bringing in an extra $6 million to bring the total for the round up to $52 million....
View ArticleClik here to view.
Philips acquires population health mgmt co. Wellcentive
Royal Philips (NYSE:PHG) said today it inked a deal to pick up population health management software dev Wellcentive for an undisclosed amount. Philips said the purchase would “compliment” its current...
View ArticleClik here to view.
Ex-Acclarent CEO, sales VP convicted in criminal case
A federal jury today convicted 2 former Acclarent executives, for the distribution of adulterated and misbranded medical devices. Former CEO William Facteau and ex-sales vice president Patrick Fabian...
View Article
